Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Alessandra Iurlo, Bruce Bank et al.|The Lancet|2023

Cited by 181